Subscribe to RSS
DOI: 10.1055/a-1925-2210
Evaluation of State-Mandated Third Trimester Repeat HIV Testing in a Large Tertiary Care Center
Funding None.![](https://www.thieme-connect.de/media/ajp/202403/lookinside/thumbnails/10-1055-a-1925-2210_22mar1146-1.jpg)
Abstract
Objective The Illinois Perinatal HIV Prevention Act was passed to ensure universal HIV testing once during pregnancy and was extended in 2018 to add third trimester repeat HIV screening. The objectives of this analysis were to describe uptake of, and patient factors associated with, third trimester repeat HIV testing at a high-volume birthing center.
Study Design This is a retrospective cohort study of people who delivered at a single tertiary care hospital in Illinois during 2018. Women who delivered before 27 weeks, had an intrauterine fetal demise, a known diagnosis of HIV, or no HIV test during pregnancy were excluded. Repeat testing was defined as an HIV test at or after 27 weeks' gestation after an earlier negative HIV test during the same pregnancy. The primary outcome was the proportion of people who received repeat testing prior to delivery. Bivariable analyses were performed to identify patient characteristics associated with documentation of repeat HIV testing.
Results Of 12,053 people eligible for inclusion, 3.4% (n = 414) presented without a documented third trimester repeat HIV test. The proportion of people with repeat testing improved from 80 to >99% in the first year. Patient factors were largely not associated with testing performance although multiparous people were more likely to have documented repeat testing.
Conclusion Rapid implementation of third trimester repeat HIV testing was achieved without disparity. Patient factors were largely not associated with testing performance which reinforces the goal of a universal screen to test all people equitably and effectively without bias.
Key Points
-
Little is known about adherence to repeat third trimester HIV testing in pregnancy.
-
Universal third trimester HIV screening was implemented with high uptake and without disparity.
-
Protocolization of repeat HIV testing in pregnancy may reduce bias compared to risk based-screening.
Publication History
Received: 28 March 2022
Accepted: 11 August 2022
Accepted Manuscript online:
16 August 2022
Article published online:
10 November 2022
© 2022. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Arabin B, Baschat AA. Pregnancy: An underutilized window of opportunity to improve long-term maternal and infant health-an appeal for continuous family care and interdisciplinary communication. Front Pediatr 2017; 5: 69
- 2 Kershaw TS, Magriples U, Westdahl C, Rising SS, Ickovics J. Pregnancy as a window of opportunity for HIV prevention: effects of an HIV intervention delivered within prenatal care. Am J Public Health 2009; 99 (11) 2079-2086
- 3 Yee LM, Simon MA, Grobman WA, Rajan PV. Pregnancy as a “golden opportunity” for patient activation and engagement. Am J Obstet Gynecol 2021; 224 (01) 116-118
- 4 American Academy of Pediatrics and American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 8th ed. Washington, DC: American College of Obstetricians and Gynecologists; 2017
- 5 Luzuriaga K, Mofenson LM. Challenges in the elimination of pediatric HIV-1 infection. N Engl J Med 2016; 374 (08) 761-770
- 6 Paintsil E, Andiman WA. Update on successes and challenges regarding mother-to-child transmission of HIV. Curr Opin Pediatr 2009; 21 (01) 94-101
- 7 Centers for Disease Control and Prevention. HIV and pregnant women, infants, and children. Accessed December 27, 2018 at: https://www.cdc.gov/hiv/group/gender/pregnantwomen/index.html
- 8 Committee on Obstetric Practice. ACOG committee opinion no. 752: prenatal and perinatal human immunodeficiency virus testing. Obstet Gynecol 2018; 132 (03) e138-e142
- 9 Barbacci MB, Dalabetta GA, Repke JT. et al. Human immunodeficiency virus infection in women attending an inner-city prenatal clinic: ineffectiveness of targeted screening. Sex Transm Dis 1990; 17 (03) 122-126
- 10 FIMR/HIV Prevention Methodology National Resource Center. Accessed February 20, 2021 at: http://www.fimrhiv.org/aboutus.php
- 11 Yee LM, Miller ES, Statton A. et al. Sustainability of statewide rapid HIV testing in labor and delivery. AIDS Behav 2018; 22 (02) 538-544
- 12 Wong AE, Garcia PM, Olszewski Y. et al. Perinatal HIV testing and diagnosis in Illinois after implementation of the Perinatal Rapid Testing Initiative. Am J Obstet Gynecol 2012; 207 (05) 401.e1-401.e6
- 13 Illinois general Assembly. Bill status of HB2800. Accessed September 27, 2022 at: https://www.ilga.gov/legislation/BillStatus.asp?DocTypeID=HB&DocNum=2800&GAID=16&SessionID=110&LegID=131654
- 14 American College of Obstetrics and Gynecology Committee on Obstetric Practice. ACOG Committee Opinion No. 418: prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol 2008; 112 (03) 739-742
- 15 Centers for Disease Control and Prevention. Preventing Perinatal HIV Transmission. Accessed April 5, 2020 at: https://hivinfo.nih.gov/understanding-hiv/fact-sheets/preventing-perinatal-transmission-hiv
- 16 Chicago Department of Public Health. HIV/STI Surveillance Report. Accessed April 20, 2020 at: https://www.chicago.gov/content/dam/city/depts/cdph/statistics_and_reports/2019_HIV_STI_REPORT_Final.pdf
- 17 Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2018. Accessed September 4, 2022 at: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-supplemental-report-vol-25-2.pdf
- 18 24/7 Illinois Perinatal HIV Hotline. Accessed April 29, 2020 at: https://www.hivpregnancyhotline.org/
- 19 Centers for Disease Control and Prevention. 2018 Quick reference guide: recommended laboratory HIV testing algorithm for serum or plasma specimens. Accessed February 15, 2021 at: https://stacks.cdc.gov/view/cdc/50872
- 20 Adhikari EH, Macias D, Gaffney D. et al. Diagnostic accuracy of fourth-generation ARCHITECT HIV Ag/Ab Combo assay and utility of signal-to-cutoff ratio to predict false-positive HIV tests in pregnancy. Am J Obstet Gynecol 2018; 219 (04) 408.e1-408.e9 , e409
- 21 Liao C, Golden WC, Anderson JR, Coleman JS. Missed opportunities for repeat HIV testing in pregnancy: implications for elimination of mother-to-child transmission in the United States. AIDS Patient Care STDS 2017; 31 (01) 20-26
- 22 Public Health – HIV Testing During Pregnancy. Published 2016; Accessed January 9, 2019 at: http://mgaleg.maryland.gov/2016RS/Chapters_noln/CH_441_hb0180t.pdf
- 23 Shuman CJ, Liu X, Aebersold ML, Tschannen D, Banaszak-Holl J, Titler MG. Associations among unit leadership and unit climates for implementation in acute care: a cross-sectional study. Implement Sci 2018; 13 (01) 62
- 24 Cassimatis IR, Ayala LD, Miller ES, Garcia PM, Jao J, Yee LM. Third-trimester repeat HIV testing: it is time we make it universal. Am J Obstet Gynecol 2021; 225 (05) 494-499
- 25 Chapman EN, Kaatz A, Carnes M. Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities. J Gen Intern Med 2013; 28 (11) 1504-1510
- 26 Owens DK, Davidson KW, Krist AH. et al; US Preventive Services Task Force. Screening for hepatitis C virus infection in adolescents and adults: US preventive services task force recommendation statement. JAMA 2020; 323 (10) 970-975
- 27 American College of Obstetricians and Gynecologists. Routine Hepatitis C Virus Screening in Pregnant Individuals. Accessed September 4, 2022 at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/05/routine-hepatitis-c-virus-screening-in-pregnant-individuals
- 28 Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC recommendations for hepatitis C screening among adults - United States, 2020. MMWR Recomm Rep 2020; 69 (02) 1-17
- 29 Boudova S, Mark K, El-Kamary SS. Risk-based hepatitis c screening in pregnancy is less reliable than universal screening: a retrospective chart review. Open Forum Infect Dis 2018; 5 (03) ofy043
- 30 Nesheim S, Jamieson DJ, Danner SP. et al. Primary human immunodeficiency virus infection during pregnancy detected by repeat testing. Am J Obstet Gynecol 2007; 197 (02) 149.e1-149.e5
- 31 Sansom SL, Jamieson DJ, Farnham PG, Bulterys M, Fowler MG. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission. Obstet Gynecol 2003; 102 (04) 782-790